Primary Infection Cohort
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 2550
Summary
- Conditions
- HIV -1 Infection
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 15 years and 125 years
- Gender
- Both males and females
Description
Objectives: Follow up of patients infected by HIV-1 for less than three months. Improve the physiological and pathological knowledge of primary HIV infection Study of the immune mechanisms involved early after infection Kinetics of viral replication and establishment of cellular reservoirs at an ear...
Objectives: Follow up of patients infected by HIV-1 for less than three months. Improve the physiological and pathological knowledge of primary HIV infection Study of the immune mechanisms involved early after infection Kinetics of viral replication and establishment of cellular reservoirs at an early stage Relationships between virological markers and immune response kinetics Impact of resistance mutations, subtype and tropism on the disease progression and the response to treatment Study of sub-groups of specific patients followed since primary infection, spontaneous or post treatment controllers, subjects with specific HLA Assessing the impact of early, transient or prolonged treatment versus deferred treatment on the long-term prognosis of patients followed since primary infection, in terms of activation / inflammation and decrease in viral reservoirs Contribute to knowledge in the epidemiology of HIV infection: Modes of transmission Sexual behavior after HIV diagnosis Calendar trend of transmitted viral strains diversity (ARV resistance and subtypes) Calendar trend of marker levels measured at primary infection Contribute to national recommendations for therapeutic care, evaluate their implementation Use observational data from the cohort for the development of therapeutic clinical trials at primary infection
Tracking Information
- NCT #
- NCT03148964
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Laurence Meyer, Professor CESP-INSERM U1018